SEARCH

SEARCH BY CITATION

References

  • Allaart, C.F. & Briët, E. (1994) Familial venous thrombophilia. In: Haemostasis and Thrombosis (eds A.L.Bloom, C.D.Forbes, D.P.Thomas et al), pp. 1349 1360. Churchill-Livingstone, New York.
  • Allaart, C.F., Poort, S.R., Rosendaal, F.R., Reitsma, P.H., Bertina, R.M., Briët, E. (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet, 341, 134 138.
  • Allaart, C.F., Rosendaal, F.R., Noteboom, W.M.P., Vandenbroucke, J.P., Briët, E. (1995) Survival in families with hereditary protein C deficiency, 1820–1993. British Medical Journal, 311, 910 913.
  • Bertina, R.M., Koeleman, R.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., De Ronde, H., Van Der Velden, P.A., Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64 67.
  • Briët, E., Van Der Meer, F., Rosendaal, F.R., Houwing-Duistermaat, J.J., Van Houwelingen, H.C. (1994) The family history and inherited thrombophilia. British Journal of Haematology, 87, 348 352.
  • Dahlbäck, B. (1995) Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood, 85, 607 614.
  • Dahlbäck, B., Carlsson, M., Svensson, P.J. (1990) Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004 1008.
  • De Ronde, H.& & Bertina, R.M. (1994) Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thrombosis and Haemostasis, 72, 880 886.
  • Greengard, J.S., Sun, X., Xu, X., Fernandez, J.A., Griffin, J.H., Evatt, B. (1994) Activated protein C resistance causes by Arg 506 Gln mutation in factor Va. Lancet, 343, 1361 1132.
  • Griffin, J.H., Evatt, B., Wideman, C., Fernández, J.A. (1993) Anticoagulant protein C pathway defective in majority of thrombophilia patients. Blood, 82, 1989 1993.
  • Hille, E.T.M., Westendorp, R.G.J., Vandenbroucke, J.P., Rosendaal, F.R. (1997) Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C). Blood, 89, 1963 1967.
  • Hirsh, J., Hull, R., Raskob, G.E. (1986) Epidemiology and pathogenesis of venous thrombosis. Journal of the American College of Cardiology, 8, 104B 113B.
  • Koster, T., Rosendaal, F.R., De Ronde, H., Briët, E., Vandenbroucke, J.P., Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 1503 1506.
  • Lane, D.A., Mannucci, P.M., Bauer, K.A., Bertina, R.M., Bochkov, N.P., Boulyjenkov, V., Chandy, M., Dahlbäck, B., Ginter, E.K., Miletich, J.P., Rosendaal, F.R., Seligsohn, U. (1996) Inherited thrombophilia: part 1 & 2. Thrombosis and Haemostasis, 76, 651 662&824 834.
  • Lensen, R.P.M., Rosendaal, R.F., Koster, T., Allaart, C.F., De Ronde, H., Vandenbroucke, J.P., Reitsma, P., Bertina, R.M. (1996) Apparent different thrombotic tendency in patients with Factor V Leiden and Protein C deficiency due to selection of patients. Blood, 88, 4205 4208.
  • Lensen, R.P.M., Bertina, R.M., De Ronde, H., Vandenbroucke, J.P., Rosendaal, F.R. (2000) Venous thrombotic risk in family members of unselected individuals with factor V Leiden. Thrombosis and Haemostasis, 83, 817 821 .
  • Mari, D., Mannucci, P.M., Duca, F., Bertolini, S., Franceschi, C. (1996) Mutant factor V (Arg506Gln) in healthy centenarians. Lancet, 347, 1044.
  • Middeldorp, S., Henkens, C.M.A., Koopman, M.M.W., Van Pampus, E.C.M., Hamulyák, K,., Van Der Meer, J., Prins, M.H., Buller, H.R. (1998) The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Annals of Internal Medicine, 128, 15 20.
  • Nachman, R.L. & Silverstein, R. (1993) Hypercoagulable states. Annals of Internal Medicine, 119, 819 827.
  • National Medical Registration of the Foundation Information Centre for Health Care (1996) SIG, Utrecht, the Netherlands.
  • Nordström, M., Lindblad, B., Bergqvist, D., Kjellström, T. (1992) A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of Internal Medicine, 232, 155 160.
  • Poort, S.R., Rosendaal, F.R., Reitsma, P.H., Bertina, R.M. (1996) A common genetic variation in the 3′- untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698 3703.
  • Prandoni, P., Lensing, A.W., Prins, M.R. (1998) Long-term outcomes after deep vein thrombosis of the lower extremities. Vascular Medicine, 3, 57 60.
  • Rees, D.C., Cox, M., Clegg, J.B. (1995) World distribution of factor V Leiden. Lancet, 346, 1133 1134.
  • Ridker, P.M., Miletich, J.P., Stampfer, M.J., Goldhaber, S.Z., Lindpaintner, K., Hennekens, C.H. (1995) Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation, 92, 2800 2802.
  • Rosendaal, F.R. (1997) Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thrombosis and Haemostais, 78 (suppl.), 1 6.
  • Rosendaal, F.R., Heijboer, H., Briët, E., Büller, H.R., Brandjes, D.P.M., De Bruin, K., Hommes, D.W., Vandenbroucke, J.P. (1991) Mortality in hereditary antithrombin-III deficiency – 1830–1989. Lancet, 337, 260 262.
  • Rosendaal, F.R., Koster, T., Vandenbroucke, J.P., Reitsma, P.H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 55, 1504 1508.
  • Simioni, P., Prandoni, P., Lensing, A.W.A., Scudeller, A., Sardella, C., Prins, M.H., Villalta, S., Dazzi, F., Girolami, B. (1997) The risk of recurrent venous thromboembolism in patients with an Arg506Gln mutation in the gene for factor V. New England Journal of Medicine, 336, 399 403.
  • Simioni, P., Sanson, B.J., Prandoni, P., Tormene, D., Friederich, P.W., Girolami, B., Gavasso, S., Huisman, M.V., Buller, H.R., Ten Cate, J.W., Girolamo, A., Prins, M.H. (1999) Incidence of venous thromboembolism in families with inherited thrombophilia. Thrombosis and Haemostasis, 81, 198 202.
  • Svensson, P.J. & Dahlbäck, B. (1994) Resistance to activated protein C as a basis for venous thrombosis. New England Journal of Medicine, 330, 517 522.
  • Van Boven, H.H., Olds, R.J., Thein, S.L., Reitsma, P.H., Lane, D.A., Briët, E., Vandenbroucke, J.P., Rosendaal, F.R. (1994) Hereditary antithrombin deficiency. Heterogeneity of the molecular basis and mortality in Dutch families. Blood, 84, 4209 4213.
  • Voorberg, J., Roelse, J., Koopman, R., Büller, H., Berends, F., Ten Cate, F.W., Mertens, K., Van Mourik, J.A. (1994) Association of idiopathic venous thromboembolism with single point mutation at Arg506 of factor V. Lancet, 343, 1535 1536.
  • Zivelin, A., Griffin, J.H., Xu, X., Pabinger, I., Samana, M., Conard, J., Brenner, B., Eldor, A., Seligsohn, U. (1997) A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood, 89, 397 402.
  • Zöller, B., Svensson, P.J., He, X., Dahlbäck, B. (1994) Identification of the same factor V gene mutation in 47 of 50 thrombosis-prone families with inherited resistance to activated protein C. Journal of Clinical Investigation, 94, 2521 2524.